A*STAR Infectious Diseases Labs (ID Labs)
What’s behind the rise of mpox?
12 Jul 2023Scientists survey how the mpox virus spreads through populations, the immunology of infections and current treatment interventions.
Spotting the mechanisms of COVID-19 organ damage
4 Jul 2023A novel tissue-profiling approach provides new insights into the mechanisms of fatal COVID-19 by analysing
different molecules and cell populations within organs.
Putting vaccine booster alternatives to the test
24 May 2023Inactivated COVID-19 vaccines could be an equally potent alternative for people with allergic sensitivities to mRNA-based vaccines.
Mixing boosters strengthen vaccine protection
24 Apr 2023An analysis of cellular immune responses reveals that mixing COVID-19 vaccines and boosters may offer enhanced protection for at-risk populations.
The war of the (malarial) roses
30 Mar 2023Drug-resistant malarial parasites form flower-like structures to shield themselves from attack by antimalarial drugs and the immune system.
Are Singaporeans vulnerable to evolving viruses?
26 Dec 2022A profile of the immune responses from Singaporean patients recovered from COVID-19 has revealed an urgent need to update vaccines against new viral variants.
Why remdesivir works for some COVID-19 patients but not others
23 Jun 2022Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.
A COVID-19 test as good as gold
3 Jun 2022A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.